| Serial Number | 90884742 |
| Word Mark | NEUROCRINE BIOSCIENCES |
| Filing Date | Monday, August 16, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Friday, August 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 13, 2022 |
| Description of Mark | The mark consists of a stylized circular spiral design with the top spiral piece in aqua blue, the right one starting is aqua blue on the left and fading to pink on the right and the left one in pink with "NEUROCRINE" above "BIOSCIENCES" in block lettering to the right where NEUROCRINE is fading from a darker shade of aqua blue on the left to a lighter shade on the right and BIOSCIENCES in gray. |
| Goods and Services | Pharmaceutical preparations for human use for treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro-immunological and neuro-endocrinological diseases, disorders, and conditions; Pharmaceutical preparations for the diagnosis, prevention and treatment of hormonal and genetic diseases, disorders and conditions; Pharmaceutical preparations for the diagnosis and prevention of psychiatric, neurological, central nervous system, and movement diseases, disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia |
| Indication of Colors claimed | The color(s) pink, gray and aqua blue is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "BIOSCIENCES" |
| Goods and Services | Pharmaceutical drug development services in the field of hormonal and genetic diseases, disorders and conditions |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 5, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 5, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Thursday, August 19, 2021 | NEW APPLICATION ENTERED |
| Tuesday, October 5, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 6, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, May 3, 2022 | ASSIGNED TO EXAMINER |
| Thursday, May 5, 2022 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Thursday, May 5, 2022 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Thursday, May 5, 2022 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Thursday, May 5, 2022 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Friday, November 4, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 4, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, November 5, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, November 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 13, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, July 14, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 14, 2023 | SOU EXTENSION 1 FILED |
| Friday, July 14, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, July 18, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 9, 2023 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, October 9, 2023 | DIVISIONAL REQUEST RECEIVED |
| Monday, October 9, 2023 | SOU EXTENSION 2 FILED |
| Monday, October 9, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 20, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, October 24, 2023 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, October 25, 2023 | CORRECTED NOA E-MAILED |
| Tuesday, October 24, 2023 | SOU EXTENSION 2 GRANTED |
| Wednesday, October 25, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 5, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 5, 2024 | SOU EXTENSION 3 FILED |
| Monday, August 5, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, February 6, 2025 | SOU EXTENSION 4 FILED |
| Thursday, February 6, 2025 | DIVISIONAL REQUEST RECEIVED |
| Thursday, February 6, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 6, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |
| Friday, August 1, 2025 | SOU EXTENSION 4 GRANTED |
| Friday, August 1, 2025 | DIVISIONAL PROCESSING COMPLETE |
| Friday, August 1, 2025 | CORRECTED NOA E-MAILED |
| Saturday, August 2, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 5, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 30, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, March 20, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, March 20, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, March 20, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |